SCHEMBL10050511

SCHEMBL10050511

COc1ccc(-c2c3nc(c(-c4ccncc4)c4ccc([nH]4)c(-c4ccc(OCCCN)cc4)c4nc(c(-c5ccncc5)c5ccc2[nH]5)C=C4)C=C3)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TOP1 P11387 2/20 0.54
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ TERT O14746 3/20 0.42
▸ ABCG2 Q9UNQ0 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ TGFBR1 P36897 1/20 0.40
▸ MAPK13 O15264 3/20 0.39
▸ MAPK12 P53778 3/20 0.39
▸ MAPK11 Q15759 3/20 0.39
▸ MAPK14 Q16539 3/20 0.39
▸ RAF1 P04049 1/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ ALOX5 P09917 2/20 0.38
▸ GCGR P47871 1/20 0.38
▸ CYCS P99999 2/20 0.38
▸ KDM4E B2RXH2 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9230080 0.94 TOP1 (0.60) TOP1CYP3A4CYP2D6TERTABCG2
SCHEMBL2549051 0.94 TOP1 (0.60) TOP1CYP3A4CYP2D6TERTABCG2
SCHEMBL10050507 0.87 TERT (0.41) TOP1TERTABCG2ALDH1A1MAPT
SCHEMBL14350959 0.82 ABCG2 (0.44) TOP1TERTABCG2ALDH1A1MAPT
SCHEMBL10050504 0.81 RAB9A (0.52) TOP1ALDH1A1MAPTMEN1KMT2A
SCHEMBL14528653 0.81 RAB9A (0.46) TOP1MAPTNPC1RAB9A
SCHEMBL10050496 0.80 MAPT (0.36) TOP1TERTABCG2ALDH1A1MAPT
Hydrochloric Acid SCHEMBL5706254 0.80 TERT (0.54) TOP1TERTABCG2MAPTNPC1
Hydrochloric Acid SCHEMBL21111503 0.80 TERT (0.54) TOP1TERTABCG2MAPTNPC1
Hydrochloric Acid SCHEMBL31122235 0.80 TERT (0.54) TOP1TERTABCG2MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8092661-B2 Electropolymerisable monomers, soluble in an aqueous solution and comprising a metalloporphyrin BIOMERIEUX (FR) 2012-01-10 — — US disclosed
US-8092661-B2 Electropolymerisable monomers, soluble in an aqueous solution and comprising a metalloporphyrin BIOMERIEUX (FR) 2012-01-10 — — US disclosed
US-20090314660-A1 Novel Electropolymerisable Monomers, Soluble in an Aqueous Solution and Comprising a Metalloporphyrin BIOMERIEUX (FR) 2009-12-24 — — US disclosed
US-20090314660-A1 Novel Electropolymerisable Monomers, Soluble in an Aqueous Solution and Comprising a Metalloporphyrin BIOMERIEUX (FR) 2009-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090314660-A1 Novel Electropolymerisable Monomers, Soluble in an Aqueous Solution and Comprising a Metalloporphyrin EPS15, PPOX, ACR TOP1 4796/4885CYP3A4 503/4885CYP2D6 3253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback